| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 39 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 35 |
| 2 | MYCOPHENOLATE MOFETIL | 34 |
| 3 | METHOTREXATE SODIUM | 30 |
| 4 | RITUXIMAB | 28 |
| 5 | AZATHIOPRINE | 27 |
| 6 | ADALIMUMAB | 26 |
| 7 | METHOTREXATE | 23 |
| 8 | TACROLIMUS | 20 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERDAFITINIB | 5 | 0.0040 |
| 1 | GOLIMUMAB | 10 | 0.0008 |
| 2 | ENFORTUMAB VEDOTIN | 5 | 0.0006 |
| 3 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 4 | BALOXAVIR MARBOXIL | 1 | 0.0004 |
| 5 | ADALIMUMAB-FKJP | 18 | 0.0004 |
| 6 | RITUXIMAB-ABBS | 2 | 0.0004 |
| 7 | FLECAINIDE ACETATE | 2 | 0.0004 |
| 8 | ADALIMUMAB-AATY | 18 | 0.0004 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 1 | Purine Antimetabolite [EPC] | 27 | 0.0003 |
| 2 | Orexin Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 30 | 0.0001 |
| 7 | Aromatase Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Microtubule Inhibitor [EPC] | 10 | 0.0001 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 23 | 0.0001 |